FDA-Inspected Site

AJES Pharmaceuticals, LLC

8 FDA inspections are on record for AJES Pharmaceuticals, LLC in Copiague, United States.

483· Form 483 issued

Copiague, United States · Last updated July 10, 2026

Overview

  • 8 FDA inspections are on record.
  • 8 inspections produced a Form 483.
  • The most recent recorded inspection date is 2024-12-09.

At a glance

Inspections

8

Form 483s

8

EIRs

1

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
2 Dec 2024 – 9 Dec 2024Foods & Cosmetics483On file
10 Nov 2022 – 21 Nov 2022Foods & Cosmetics483On file
5 Oct 2021 – 14 Oct 2021Foods & Cosmetics483On file
8 Mar 2018 – 29 Mar 2018Foods & Cosmetics483On file
23 Feb 2016 – 9 Mar 2016Foods & CosmeticsWLOn file
14 Jul 2014 – 18 Jul 2014Foods & Cosmetics483On file
28 Jun 2013 – 11 Jul 2013Foods & Cosmetics483On file
4 Oct 2010Not recorded483On file

Observations on record

Form 483 observations cited at this site, most recent first.

9 Dec 2024
21 CFR 111.210

Master manufacturing record - record requirements

Cited by Meredith P Soehl

9 Dec 2024
21 CFR 111.255(b)

Batch record - complete

Cited by Meredith P Soehl

9 Dec 2024
21 CFR 111.255(c)

Batch record - follow master

Cited by Meredith P Soehl

9 Dec 2024
21 CFR 111.315(d)

Standard reference materials; criteria for selecting

Cited by Meredith P Soehl

9 Dec 2024
21 CFR 111.553

Written procedures - follow; product complaint

Cited by Meredith P Soehl

Investigators

FDA investigators tied to this site in the record.

Erica B Raphael1 insp.
Christopher S Fields1 insp.
Charanjeet Jassal1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 111.315(d)Cited across public-safe Form 483 observations4x
21 CFR 111.75(c)Cited across public-safe Form 483 observations4x
21 CFR 111.95(b)(3)Cited across public-safe Form 483 observations3x
21 CFR 111.113(b)(2)Cited across public-safe Form 483 observations2x
21 CFR 111.255(b)Cited across public-safe Form 483 observations2x
21 CFR 111.35(b)(3)Cited across public-safe Form 483 observations2x
21 CFR 111.73Cited across public-safe Form 483 observations2x
21 CFR 111.75(a)(1)(i)Cited across public-safe Form 483 observations2x
21 CFR 111.75(h)(2)Cited across public-safe Form 483 observations2x
FDCA 761(b)(1)Cited across public-safe Form 483 observations2x
21 CFR 111.155(e)Cited across public-safe Form 483 observations1x
21 CFR 111.20(c)(3)Cited across public-safe Form 483 observations1x
21 CFR 111.210Cited across public-safe Form 483 observations1x
21 CFR 111.210(b)Cited across public-safe Form 483 observations1x
21 CFR 111.210(h)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.210(h)(5)Cited across public-safe Form 483 observations1x
21 CFR 111.25(a)Cited across public-safe Form 483 observations1x
21 CFR 111.255(c)Cited across public-safe Form 483 observations1x
21 CFR 111.260(g)Cited across public-safe Form 483 observations1x
21 CFR 111.260(l)(4)Cited across public-safe Form 483 observations1x
21 CFR 111.27(b)Cited across public-safe Form 483 observations1x
21 CFR 111.27(d)Cited across public-safe Form 483 observations1x
21 CFR 111.320(b)Cited across public-safe Form 483 observations1x
21 CFR 111.325(b)(2)(i)Cited across public-safe Form 483 observations1x
21 CFR 111.360Cited across public-safe Form 483 observations1x
21 CFR 111.430(a)Cited across public-safe Form 483 observations1x
21 CFR 111.553Cited across public-safe Form 483 observations1x
21 CFR 111.560(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.605Cited across public-safe Form 483 observations1x
21 CFR 111.70(b)Cited across public-safe Form 483 observations1x
21 CFR 111.70(b)(1)Cited across public-safe Form 483 observations1x
21 CFR 111.70(e)Cited across public-safe Form 483 observations1x
21 CFR 111.83(b)(3)Cited across public-safe Form 483 observations1x
21 CFR 111.90(a)(1)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind AJES Pharmaceuticals, LLC's 8 Form 483s

Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat

Related sites